BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 30917830)

  • 1. Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis.
    Kim HS; Park JB; Gwak HS; Kwon JW; Shin SH; Yoo H
    World J Surg Oncol; 2019 Mar; 17(1):59. PubMed ID: 30917830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid diversion and outcomes for lung cancer patients with leptomeningeal carcinomatosis.
    Su YH; Chiang CL; Yang HC; Hu YS; Chen YW; Luo YH; Chen CJ; Wu HM; Lin CJ; Lee CC
    Acta Neurochir (Wien); 2022 Feb; 164(2):459-467. PubMed ID: 33646444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes following cerebrospinal fluid shunting in high-grade glioma patients.
    Rinaldo L; Brown D; Lanzino G; Parney IF
    J Neurosurg; 2018 Oct; 129(4):984-996. PubMed ID: 29271709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Palliative shunt surgery for patients with leptomeningeal metastasis.
    Murakami Y; Ichikawa M; Bakhit M; Jinguji S; Sato T; Fujii M; Sakuma J; Saito K
    Clin Neurol Neurosurg; 2018 May; 168():175-178. PubMed ID: 29567579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Palliative Cerebrospinal Fluid Shunting for Patients With Leptomeningeal Carcinomatosis-related Hydrocephalus.
    Yoshioka H; Okuda T; Nakao T; Fujita M; Takahashi JC
    Anticancer Res; 2021 Aug; 41(8):4169-4172. PubMed ID: 34281889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in cerebrospinal fluid shunting in patients with glioblastoma.
    Hong B; Polemikos M; Heissler HE; Hartmann C; Nakamura M; Krauss JK
    Fluids Barriers CNS; 2018 Jun; 15(1):16. PubMed ID: 29860942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lumboperitoneal shunts in managing chronic hydrocephalus with slit ventricles.
    Marupudi NI; Harris C; Pavri T; Mell B; Singh R; Ham SD; Sood S
    J Neurosurg Pediatr; 2018 Dec; 22(6):632-637. PubMed ID: 30239284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative course of cerebrospinal fluid diversion in the setting of leptomeningeal disease: a systematic review, meta-analysis, and meta-regression with an illustrative case.
    Lu VM; Abou-Al-Shaar H; Bin-Alamer O; Luther EM; Benjamin CG
    J Neurooncol; 2023 May; 163(1):29-37. PubMed ID: 37191912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is the risk of a shunt malfunction after elective intradural surgery?
    Venable GT; Green CS; Smalley ZS; Bedford EC; Modica JS; Klimo P
    J Neurosurg Pediatr; 2015 Dec; 16(6):642-7. PubMed ID: 26359674
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer.
    Ko Y; Gwak HS; Park EY; Joo J; Lee YJ; Lee SH; Kwon JW; Shin SH; Yoo H
    J Neurooncol; 2019 Jul; 143(3):553-562. PubMed ID: 31089925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lumboperitoneal and Ventriculoperitoneal Shunt Surgery for Posthemorrhagic Communicating Hydrocephalus: A Comparison.
    Wang Z; Wang K; Qian Z; Zeng L; Gao L
    World Neurosurg; 2019 Jul; 127():e638-e643. PubMed ID: 30947009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lumboperitoneal Shunt: A New Modified Surgical Technique and a Comparison of the Complications with Ventriculoperitoneal Shunt in a Single Center.
    Yang TH; Chang CS; Sung WW; Liu JT
    Medicina (Kaunas); 2019 Sep; 55(10):. PubMed ID: 31561485
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy of lumbo-peritoneal versus ventriculo-peritoneal shunting for management of chronic hydrocephalus following aneurysmal subarachnoid haemorrhage.
    Kang S
    Acta Neurochir (Wien); 2000; 142(1):45-9. PubMed ID: 10664375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative cerebrospinal fluid shunting for leptomeningeal metastasis-related hydrocephalus in patients with lung adenocarcinoma: A single-center retrospective study.
    Mitsuya K; Nakasu Y; Hayashi N; Deguchi S; Takahashi T; Murakami H; Naito T; Kenmotsu H; Ono A; Wakuda K; Harada H
    PLoS One; 2019; 14(1):e0210074. PubMed ID: 30629621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of surgically treated hydrocephalus in leptomeningeal metastases.
    Jung TY; Chung WK; Oh IJ
    Clin Neurol Neurosurg; 2014 Apr; 119():80-3. PubMed ID: 24635931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcome and Safety of Lumboperitoneal Shunt in the Treatment of Non-Obstructive Hydrocephalus.
    Foo NP; Tun YC; Chang CC; Lin HL; Cheng CH; Chuang HY
    Clin Interv Aging; 2023; 18():477-483. PubMed ID: 36994429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lumboperitoneal shunt: clinical applications, complications, and comparison with ventriculoperitoneal shunt.
    Aoki N
    Neurosurgery; 1990 Jun; 26(6):998-1003; discussion 1003-4. PubMed ID: 2362678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of lumboperitoneal shunt versus ventriculoperitoneal shunt in post meningitis communicating hydrocephalus in children.
    Singh A; Vajpeyi IN
    Neurol India; 2013; 61(5):513-6. PubMed ID: 24262455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the Preoperative Radiological Risk Features in Patients with Leptomeningeal Carcinomatosis Undergoing Cerebrospinal Fluid Drainage.
    Hou Q; Mo Y; Guo J; Deng T; Mo L; Wei C
    World Neurosurg; 2024 Apr; ():. PubMed ID: 38593911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pediatric hydrocephalus: 40-year outcomes in 128 hydrocephalic patients treated with shunts during childhood. Assessment of surgical outcome, work participation, and health-related quality of life.
    Paulsen AH; Lundar T; Lindegaard KF
    J Neurosurg Pediatr; 2015 Dec; 16(6):633-41. PubMed ID: 26359766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.